Press "Enter" to skip to content

AbbVie Receives Positive Recommendation from the Institut national d’excellence en santé et en services sociaux (INESSS) for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia – Canada NewsWire

admin 0

AbbVie Receives Positive Recommendation from the Institut national d’excellence en santé et en services sociaux (INESSS) for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia  Canada NewsWire

INESSS recommends the reimbursement of VENCLEXTA® (venetoclax) in combination with rituximab for the treatment of adult patients with chronic lymphocytic …

“lymphoma cancer” – Google News

(Visited 6 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *